Previous Article | Next Article 
Journal of Virology, October 2001, p. 9896-9908, Vol. 75, No. 20
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9896-9908.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Chromosomal Integration Pattern of a
Helper-Dependent Minimal Adenovirus Vector with a Selectable Marker
Inserted into a 27.4-Kilobase Genomic Stuffer
Moritz
Hillgenberg,1,2,*
Holger
Tönnies,3 and
Michael
Strauss2
DeveloGen AG, D-13125
Berlin-Buch,1 Humboldt-Universität
zu Berlin, AG Molekulare Zellbiologie, D-13122
Berlin-Buch,2 and
Humboldt-Universität zu Berlin, Medizinische
Fakultät, Institut für Humangenetik, Molekulare
Zytogenetik, Campus Virchow-Klinikum, D-13353
Berlin,3 Germany
Received 22 January 2001/Accepted 7 July 2001
 |
ABSTRACT |
Helper-dependent minimal adenovirus vectors are promising tools for
gene transfer and therapy because of their high capacity and the
absence of immunostimulatory or cytotoxic viral genes. In order to
characterize this new vector system with respect to its integrative
properties, the integration pattern of a minimal adenovirus vector with
a neor gene inserted centrally into a noncoding
27.4-kb genomic stuffer element derived from the human X chromosome
after infection of a sex chromosome aneuploid (X0) human glioblastoma
cell line was studied. Our results indicate that even extensive
homologies and abundant chromosomal repeat elements present in the
vector did not lead to integration of the vector via homologous or
homology-mediated mechanisms. Instead, integration occurred primarily
by insertion of a monomer with no or little loss of sequences at the
vector ends, apparently at random sites, which is very similar to
E1 deletion adenovirus vectors. It is therefore unlikely that
the incorporation of stuffer elements derived from human genomic DNA, which were shown to allow long-term transgene expression in vivo in a
number of studies, leads to an enhanced risk of insertional mutagenesis. Furthermore, our findings indicate that the potential of
minimal adenovirus vectors as tools for targeted insertion and gene
targeting is limited despite the possibility of incorporating long
stretches of homologous sequences. However, we found an enhanced efficiency of stable neor transduction of the
minimal adenovirus vector compared to an E1 deletion adenovirus vector,
possibly caused by the absence of potential growth-inhibitory
viral genes. Complete integration of the vector and tolerance of the
integrated vector sequences by the cell might indicate a
potential use of these vectors as tools for stable transfer of (large) genes.
 |
INTRODUCTION |
Recombinant adenovirus
vectors are promising vehicles for many gene delivery applications in
molecular biology and medicine because of their high cellular
transduction efficiency. First-generation adenovirus vectors based on
human adenovirus serotype 5 (Ad5) are rendered replication deficient by
deletion of the E1 region and can accommodate inserts of up to 8 kb
(reviewed in reference 3). The potential of these vectors
for gene therapy applications is limited by the rapid loss of transgene
expression in vivo. Residual expression of adenovirus genes was shown
to induce a cytotoxic-T-lymphocyte-mediated immune response, resulting
in inflammation and loss of vector-transduced cells (11, 71, 72,
73). To overcome these limitations, we and others have developed
helper-dependent adenovirus vectors with all viral coding sequences
deleted (20, 26, 29, 33, 35, 40, 52, 56). These
vectors
termed minimal adenovirus vectors herein
were shown to
mediate prolonged transgene expression and to exhibit reduced tissue
toxicity in vivo compared to E1 deletion adenovirus vectors in a number
of recent studies (8, 9, 42, 43, 44, 57, 76).
Minimal adenovirus vectors containing only a heterologous expression
unit and the cis-acting adenovirus signal elements (inverted terminal repeats [ITRs] and packaging signal) would usually be much
smaller than wild-type adenovirus. Vectors of this size amplify less
efficiently or multimerize (20, 25, 44). As this
phenomenon was correlated to a lower packaging limit of Ad5 (1,
50), stuffer sequences are added to provide a packageable genome
size. It has been shown that nature of the stuffer has a substantial influence on transgene expression in vivo. Long-term gene expression was observed with stuffers composed of noncoding human genomic sequences (8, 42, 44, 56, 57). In contrast, rapid loss of
transgene expression was observed with a stuffer derived from phage
lambda and could be correlated with a stuffer-directed cellular immune
response (51). We have recently developed a cosmid-based system for simple and efficient construction of minimal adenovirus vectors. As a stuffer for transgene insertion a noncoding genomic fragment from the human X chromosome was used (29).
Minimal adenovirus vectors with stuffer elements derived from human
chromosomal DNA differ from E1 deletion adenovirus vectors not only by
the absence of viral genes but also by the presence of homologies to
the genome of human target cells. It has been suspected that the latter
might lead to a more frequent integration into the host cell chromosome
by homologous or homology-related recombination mechanisms
(56).
In nonpermissive cells, wild-type adenovirus persists as an episome in
the nucleus and can occasionally integrate into the cellular genome via
an as-yet-unknown mechanism. In permissive cells (productive
infection), recombinations between viral and cellular DNA can also
occur, as evidenced by the emergence of recombinant viruses that
contain cellular DNA (for a review see reference 17).
Adenoviruses encoding a temperature-sensitive DNA-binding protein yield
stable clones at the nonpermissive temperature (21). E1
deletion adenovirus vectors carrying selectable genes were shown to
integrate at frequencies of ~10
3 to 10
5
into cultured mammalian cells (27, 32, 62). The
integration of E1 deletion adenovirus vectors was found to primarily
occur as monomers with no or little loss of sequences at the vector end, apparently at random sites (27, 31, 61, 62).
Occasionally, multiple copies of vector DNA arranged in tandem arrays
were also observed (27, 62). These integrative properties
have been exploited to generate cell lines that stably express
nonselectable transgenes (31) or to produce transgenic
mice by adenovirus-mediated gene transfer into fertilized eggs
(61). Furthermore, targeted correction of mutant
neor genes with E1+ or
E1
adenovirus vectors carrying an intact gene has also been reported
(22, 41, 66).
The influence on integration behavior of extensive homologies shared by
adenovirus vectors and the target cell genome has not been studied
before. In the present study, the integration pattern of a
helper-dependent minimal adenovirus vector with a neor gene inserted centrally into a 27.4-kb
continous noncoding genomic stuffer derived from the human X chromosome
was investigated. We were interested to evaluate whether the
incorporation of genomic stuffer elements could lead to an enhanced
risk of insertional mutagenesis. Furthermore, we wanted to study the
potential of minimal adenovirus vectors as tools for gene targeting
strategies, as the high capacity of these vectors allows the insertion
of long stretches of homologous sequences. Finally, we also wanted to
evaluate the potential of minimal adenovirus vectors as tools for
stable transfer of large genes or complex genetic elements. In order to
clarify whether extensive homologies lead to an enhanced integration
rate and/or an altered integration pattern, the efficiency of the
minimal adenovirus vector in stably transducing the
neor gene after infection of a sex chromosome
aneuploid (X0) human glioblastoma cell line was compared to that of an
E1 deletion adenovirus vector and the integrated minimal adenovirus
vector sequences were characterized.
 |
MATERIALS AND METHODS |
Cells and viruses.
The E1-transformed human embryonic kidney
cell line 293 (24), the human hepatoma cell line Huh7
(45), and the human glioblastoma cell line U87-MG
(54) were maintained in Dulbecco's modified Eagle's
medium (Gibco-BRL Life Technologies, Paisley, Scotland, United Kingdom)
supplemented with 2 mM glutamine (Sigma, Deisenhofen, Germany),
antibiotics (penicillin and streptomycin), and 10% fetal calf serum
(Roche Diagnostics, Mannheim, Germany). The cultures were incubated at
37°C in a humidified atmosphere with 5% CO2. The
helper-dependent minimal adenovirus MVX-lacZneo was
constructed using a cosmid-based cloning system and was amplified with
a
E1 helper virus containing a packaging signal flanked by
loxP sites on a Cre recombinase-expressing packaging cell
line derived from 293 cells as described in detail elsewhere
(29). MVX-lacZneo was partially purified from
helper virus by CsCl density gradient centrifugation. The final
preparation contained 1.65 × 1011 viral particles/ml
as determined by measurement of the optical density at 260 nm
(37). Contamination with helper virus was ~25% as
judged by restriction analysis of DNA extracted from purified virus.
Ad
E1neo and AdRSV
gal (59) are
first-generation (
E1) adenovirus vectors that contain the same
neor cassette as MVX-lacZneo or Rous
sarcoma virus promoter-driven Escherichia coli lacZ
expression cassette, respectively, inserted into the E1 region.
Ad
E1neo was constructed using p
E1sp1A (4) as a shuttle vector for the insertion into the E1 region and was rescued by cotransfection with pJM17 (38) onto 293 cells.
The
E1 viruses were amplified on 293 cells and purified by CsCl
banding as described elsewhere (30), and titers were
determined by dilution endpoint assay on 293 cells. Contamination with
replication-competent adenovirus was determined for
MVX-lacZneo and Ad
E1neo as described previously (28) and was below 1/107 infectious
particles (IP) for both viruses.
Comparative Southern blot-based titration of
MVX-lacZneo.
Huh7 cells were infected with various
multiplicities of infection (MOIs) of Ad
E1neo (ranging
from 10 to 300 IP/cell as determined by dilution endpoint assay) and
MVX-lacZneo (ranging from 300 to 9,000 VP/cell) for 1 h
in phosphate-buffered saline (PBS)-1 mM MgCl2, thoroughly
washed with PBS, and replenished with medium. Total DNA was extracted
from the cells at 6 h postinfection and digested with
NcoI, which releases an 894-bp fragment from the neor cassette contained in both viruses (see
Fig. 1A). Southern blot analysis was performed using a radiolabeled
probe specific for this fragment, and signal intensities were
quantitated. This method was shown previously to detect only DNA from
infectious virus that has been transported to the nucleus
(6). Signal intensities generated with a given MOI of
Ad
E1neo (3 × 109 IP/ml) correlated with
signal intensities generated after infection with a nine-fold-higher
number of viral particles/cell of MVX-lacZneo (1.65 × 1011 VP/ml), indicating a titer of 1.8 × 1010
IP/ml for the latter.
Selection and analysis of G418 resistant clones.
U87-MG
cells (106) in 25-cm2 cell culture flasks were
infected with the viruses at the various MOIs in a total volume of 1 ml of PBS-1 mM MgCl for 1.5 h at room temperature, washed with PBS, and replenished with medium. At 2 days postinfection G418 (Gibco-BRL Life Technologies) was added at a final concentration of 250 µg/ml. Medium was changed twice weekly, and clones were allowed to grow for
~5 weeks. For clone counts cells were stained with methylene blue.
For characterization of MVX-lacZneo integration pattern a
total of 200 clones were generated under conditions that allowed single
clones to be isolated with a minimal risk of cross-contamination (infection with an MOI of 0.01 IP/cell, resulting in ~10 to 20 clones
per cell culture flask) and expanded individually under G418 selection.
For PCR or Southern blot analyses, genomic DNA was extracted from one
confluent 150-mm-diameter dish each. To analyze
-galactosidase
activity, cells were plated into six-well plates and stained with
5-bromo-4-chloro-3-indolyl-
-D-galactoside (X-Gal)
following standard protocols.
PCR analysis.
For each clone, 100 ng of genomic DNA were
used for PCR with primers PNeo1H (5'-TTCTCACTGCTGCTGTCCTA-3')
and PNeo1R (5'-GGCAACTTGCTGGCACTGTA-3'), which bind
470 bp upstream or 272 bp downstream, respectively, of the
SnaBI site at the X-chromosomal target region (see Fig. 4A),
into which the neor cassette had been inserted
in MVX-lacZneo (29). As controls for the
unmodified target region DNA from original U87-MG cells and
pMVX-lacZ, a cosmid that contains the unmodified
X-chromosomal target region (29) was used. As a control
for the modified target region pMVX-lacZneo was used, the
cosmid vector from which minimal adenovirus MVX-lacZneo had
been derived (29). The reaction was performed in a total
volume of 25 µl with 35 cycles of 45 s at 94°C, 45 s at
55°C, and 40 s at 72°C in a PCT-100 thermocycler (MJ Research)
using Platinum Taq (Gibco-BRL Life Technologies) with 2 mM
MgCl2, 5% dimethyl sulfoxide, 0.2 mM deoxyribonucleotide triphosphates and primers at 1 µM each. As a number of unspecific bands arose from this first amplification, 1 µl of the product was
used for a second (nested) PCR carried out under the same conditions to
unequivocally visualize a specific product. Primers PNeo2H
(5'-CCTCTGCCTTGACATGACCT-3') and PNeo2R
(5'-GGACAATGGAGATCAATGCC-3') bind 281 bp upstream and 248 bp
downstream of the SnaBI site, respectively, and give rise to
a 529-bp product from the unmodified target region. The 2,063-bp
product resulting from the modified target region with the
neor cassette inserted into the SnaBI
site was not amplified under these conditions. Therefore, the protocol
served only to detect presence or absence of the unmodified target
region. Analysis was done in duplicate in two seperate experiments for
each clone.
Southern blot analysis.
Digested DNAs (15 µg each) were
seperated over 1% agarose gels and blotted onto Hybond-N+ membranes
(Amersham). Radiolabeling of probes, hybridization, and washing were
performed following standard procedures. An 894-bp NcoI
fragment from the neor cassette (see Fig. 1A)
was used as a probe for comparative Southern blot titration and for the
detection of the neor cassette in
U87-MGneor clones. A 473-bp XhoI
fragment from pMVX-lacZneo (29) was used to
detect X-chromosomal sequences as indicated in Fig. 4A (X probe). A
341-bp fragment containing bp 189 to 526 from the adenovirus 5' end
(
probe) and a 415-bp fragment containing part of the simian virus
40 (SV40) polyadenylation signal (SV40pA probe) were used as probes for
the detection of integrated minimal adenovirus 5' and 3' ends,
respectively (see Fig. 5). Hybridizing bands were visualised by
exposure to Kodak Biomax MR films, and band intensities were measured
using a Fujix BAS 2000 phosphorimager (Fuji, Tokyo, Japan).
Localization of repeat elements.
The X-chromosomal backbone
in MVX-lacZneo was analyzed for the presence of chromosomal
repeat elements using RepeatMasker version 5/99 programmed by A.F.A.
Smit and P. Green at default settings with Repbase version 3.04 at http://repeatmasker.genome.washington.edu/cgi-bin.RM2_req.pl. and with BLAST2.0 search (2) using public sequence
databases at http://www.ncbi.nlm.nih.gov/cgi-bin/BLAST.
FISH.
Harvesting and chromosome preparation for molecular
and cytogenetic analysis followed standard procedures. For
X-chromosome-specific chromosome paint, fluorescence in situ
hybridization (FISH) with an indirect labeled coatasome probe for
chromosome X (Oncor) was used following the instructions of the
manufacturer. The digoxigenin-labeled coatasome was detected by
fluorescein isothiocyanate-conjugated antidigoxigenin antibody (Oncor).
For the detection of integration sites of MVX-lacZneo, FISH
with pMVX-lacZneo was performed. Probe DNA was labeled by
nick translation with SpectrumOrange-dUTP (nick translation kit;
VYSIS). Probe length after nick translation was 100 to 400 bp. To avoid
background fluorescence, the slides were treated with RNase (stock
solution: 20 mg of RNase A per ml, 10 mM Tris-HCl [pH 7.5], 15 mM
NaCl) prior to hybridization. Chromosome preparations were equilibrated
in 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at room
temperature and incubated with RNase (100 µg/ml) at 37°C for 1 h. After washing twice in 2× SSC at room temperature, slides were
dehydrated through alcohol grades (70%, 85%, 2× absolute ethanol).
Chromosomal DNA was denatured with 70% formamide-2× SSC at 70°C
for 5 min and quickly transferred to ethanol grades. For each
hybridization, 80 ng of labeled DNA, 2.5 µg of Cot-1 DNA, and
glycogen were mixed and precipitated with sodium acetate (3 M) and
isopropanol. Human highly repetitive DNA (Cot-1 DNA) was used to
precipitate the small probe DNA, to block nonspecific sticking
of probe DNA to cytoplasm, and to prevent repetitive sequences
interspersed within the unique sequences of the probe from hybridizing
to target DNA located all over in the human genome (53,
69). DNA was resuspended in 10 µl of hybridization mixture
containing 50% formamide, 2× SSC, and 10% dextran sulfate, denatured
at 73°C for 5 min, and hybridized to denatured target metaphase
spreads. Slides were incubated at 37°C in a moist chamber overnight.
Posthybridization washes were performed in 0.4× SSC-0.3% NP-40 at
73°C for 2 min. A second incubation was done in 2× SSC-0.1% NP-40
at room temperature for 30 s. Chromosomes were counterstained with
4,6-diamino-2-phenylindole (DAPI), and slides were mounted in
Vectashield antifade solution (Vector). Hybridizations were analyzed
using an epifluorescence microscope (Axioscope; Zeiss) equipped with a
cooled charge coupled device camera (Hamamatsu). Image analysis was
performed with an ISIS system (Metasystems, Altlussheim, Germany).
 |
RESULTS |
Integration frequency of MVX-lacZneo.
The
helper-dependent minimal adenovirus vector MVX-lacZneo
(29) contains the 5'-terminal 526 bp (5' ITR and packaging
signal), the 3'-terminal 157 bp (3' ITR) of Ad5, and a human
cytomegalovirus (CMV) immediate early promoter-driven neomycin
resistance gene (neor) cassette centrally
inserted into a 27.4-kb noncoding genomic stuffer derived from the
human X chromosome. Furthermore, it contains an E. coli lacZ
reporter gene cassette located at the 3' end (Fig. 1A). As a model system to study
chromosomal integration of MVX-lacZneo we chose U87-MG, a
hypodiploid human glioblastoma cell line which is monosomic for the X
chromosome (54). The presence of a single X chromosome in
U87-MG cells was verified by X-chromosome-specific paint, and the
presence of the homologous target region (the chromosomal fragment
inserted into MVX-lacZneo) was verified by PCR (data not
shown). Furthermore, U87-MG cells were found to be highly susceptible
to adenovirus infection, as determined by staining of cells for
-galactosidase activity after infection with AdRSV
gal (~60% or
95% transduced cells after infection with an MOI of 10 or 50 IP/cell,
respectively).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1.
Structures and titration of Ad E1neo and
MVX-lacZneo. (A) Both viruses contain a neomycin resistance
gene (neor) cassette controlled by the human CMV
immediate early promotor and the bovine growth hormone polyadenylation
signal (bGHpA). Ad E1neo is a first-generation adenovirus
vector that contains the neor cassette inserted
into the E1 region. Minimal adenovirus MVX-lacZneo has
the neor cassette inserted centrally in a
27.4-kb noncoding genomic stuffer derived from the human X chromosome.
Furthermore, the vector contains a lacZ expression cassette
controlled by the Rous sarcoma virus promoter and the SV40
polyadenylation signal (SV40pA) at the 3' end. Repeat elements in the
X-chromosomal backbone are indicated (Table 1). The Ad5 ITRs and the
packaging signal ( ) are also shown. (B) Verification of infectious
titers as determined by a comparative Southern blot-based titration
protocol. DNA extracted from Huh7 cells after infection with the
viruses at the indicated MOIs was digested with NcoI, and
the 894-bp fragment generated from the neor
cassette was detected (PC, positive controls [purified NcoI
fragment from the neor cassette]; NC, negative
control [DNA from mock-infected Huh7 cells]).
|
|
We were first interested to investigate integration frequencies of
MVX-
lacZneo compared to those of the first-generation
adenovirus
vector Ad

E1
neo, which contains the same
neor cassette as MVX-
lacZneo inserted
into the E1 region (Fig.
1A).
In order to compare integration
frequencies it was necessary to
adjust infectious viral titers with
respect to the efficiency
for transducing DNA containing the
neor cassette. To this end, a comparative
Southern blot protocol was
used, based on the quantification of
transduced
neor sequences after infection of
cells with various MOIs of the viruses,
as described in Materials and
Methods. Titers were verified by
repetition of the procedure with MOIs
of 11, 33, 100, and 300
IP/cell for both viruses (Fig.
1B). To
investigate integration
frequencies, U87-MG cells were infected with
the viruses at MOIs
ranging from 0.003 to 1 IP/cell and selected for
G418 resistance,
which is conferred by the
neor
gene. No G418-resistant clones arose after mock infection or
infection
with AdRSV

gal in control experiments (data not shown).
In contrast,
G418-resistant clones (termed U87-MG
neor clones
herein) grew after infection with MVX-
lacZneo and
Ad

E1
neo,
indicating integration of the
neor sequences. Clone numbers reflected the
different MOIs used and
were on average ~10-fold higher with
MVX-
lacZneo (Fig.
2). Apparent
integration frequencies were determined as the 100-fold ratio
of the
number of clones generated to the total number of infectious
particles
used for the infection and corresponded to ~0.18% and
~0.02% for
MVX-
lacZneo and Ad

E1
neo, respectively.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 2.
Apparent chromosomal integration frequencies of
Ad E1neo and MVX-lacZneo. U87-MG cells
(106) were infected with the viruses at the MOIs indicated
and selected with G418. After 5 weeks, clones were stained and counted.
Each experiment was done in triplicate. Representative results are
shown (A). The average number of clones per 106 cells
generated after infection with the viruses at MOIs of 0.01, 0.03, and
0.1 is also shown (B). Bars represent standard deviations.
|
|
Enhanced apparent integration frequency does not correlate with
repeat-mediated integration of MVX-lacZneo sequences.
We first suspected that the enhanced apparent integration frequency of
MVX-lacZneo might reflect a higher rate of chromosomal integration mediated by the homologies shared by the vector and the
host cell genome. Alu and L1 elements constitute the
majority of short and long interspersed repetitive elements (SINEs and LINEs), respectively, and account for approximately 5% of the human
genome each (recently reviewed in references 39 and 48). Thus, a high number of potential targets might lead to integration by
homology-related mechanisms, if the vector contains repeat elements.
Therefore, the X-chromosomal backbone in MVX-lacZneo was
screened for repeat elements that may contribute to its integration behavior (Table 1). Four complete
Alu elements and two 5'-truncated L1 elements were found.
Importantly, the neor cassette in
MVX-lacZneo was found to be flanked by an L1 and an
Alu repeat element. Integration of the
neor cassette in MVX-lacZneo by
homology-like recombination between the flanking L1 and/or
Alu element and their abundant counterparts in the genome of
U87-MG cells would lead to a loss of vector sequences, which are
located upstream of the L1 and/or downstream of the AluSq
element, respectively. This could be monitored by the presence or
absence of the restriction sites for BglII and
BamHI, which flank the L1 and the AluSq element
in MVX-lacZneo, respectively (Fig.
3A). We therefore performed Southern blot
analysis of BamHI/BglII-digested DNA from 16 U87-MGneor clones using a probe specific for the
neor open reading frame (ORF) (Fig. 3B). In no
case was loss of these sites observed. Instead, a fragment
corresponding to the original fragment generated from
MVX-lacZneo was detected in all clones. It was present at
different copy numbers, as indicated by various signal intensities.
Thus, the integration of the neor cassette had
in no case been mediated by homology-related recombination events via
the L1 or AluSq element.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Southern blot analysis for the involvement of L1 and
AluSq elements in MVX-lacZneo integration. (A)
The integration of MVX-lacZneo via homology-mediated
recombination involving the L1 and/or the AluSq element
flanking the neor cassette and their abundant
cellular counterparts would lead to loss of the BgIII and/or
BamHI site flanking these elements, resulting in
BglII/BamHI fragments containing
neor sequences with sizes different from the
3,492 bp generated from the complete vector. (B) Genomic DNA from
U87MGneor clones 1 through 16 was digested with
BglII and BamHI and hybridized with the 894-bp
NcoI fragment (Fig. 1A) to detect
neor sequences. As positive controls (PC),
BglII/BamHI-digested pMVX-lacZneo
corresponding to one and three copies/cell was used. DNA from original
U87-MG cells was used as a negative control (NC).
|
|
Lack of homologous targeting of MVX-lacZneo sequences
to the X-chromosomal target site.
The previous results could have
been indicative of (i) unspecific integration of a large proportion of
the vector or (ii) targeted insertion into the X chromosome via a
double-crossover event. The neor cassette in
MVX-lacZneo is flanked by 13.8 and 13.6 kb of sequences homologous to the target region in the X chromosome (Fig.
4A). Gene targeting is most efficient
using linearized replacement type vectors which contain the transgene
flanked on both sides with sequences that are homologous the target
region (for a recent review see reference 70).
Furthermore, the frequency of targeted insertion by a double-crossover
event depends on the length of the flanking homologous sequences and
was shown to be saturated at a length of 14 kb (14). Thus,
MVX-lacZneo would represent a replacement-type vector for
gene targeting with optimal length of flanking homologous DNA
sequences. We therefore wanted to analyze whether the higher apparent
integration frequency of MVX-lacZneo might be correlated
with targeted insertion into the homologous target region in the single
X chromosome of U87-MG cells. To this end, genomic DNA from
U87-MGneor clones 1 through 16 was analyzed by
PCR over the X-chromosomal target site (Fig. 4B). The characteristic
product for the unmodified X-chromosomal target region was present in
all clones, indicating that a homologous targeting to the X-chromosomal
site had not occurred. These results were verified by Southern blot
analysis using BamHI/BglII-digested DNA from
U87-MG clones 1 through 16 and a probe specific for the X-chromosomal
sequence between the neor cassette and the
AluSq element. Two hybridizing bands were detected in all
clones (Fig. 4C): the signal from the integrated MVX-lacZneo sequences and a signal from the unmodified target site on the X
chromosome. It was thus clear that homologous targeting was not the
reason for the enhanced apparent integration frequency of
MVX-lacZneo. However, we wanted to further examine the
potential of minimal adenovirus vectors to target a specific
chromosomal site. Therefore, another 184 U87-MGneor clones were analyzed by PCR over the
X-chromosomal target site. Again, with all clones the product
characteristic of the unmodified target site was detected (data not
shown). Thus, despite the long homologous stretches on both sides of
the neor cassette in MVX-lacZneo, no
homologous targeting event could be detected in a total of 200 clones
tested.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 4.
Analyses for targeted insertion of
MVX-lacZneo. (A) The neor cassette in
MVX-lacZneo is flanked with 13.8 and 13.6 kb of sequences on
the 5' and 3' sides respectively, which are homologous to the target
site on the single X chromosome in U87-MG cells. Site-specific
integration would lead to loss of the original structure of the target
site, which would be detected by the absence of the 529-bp product
generated by nested PCR over the SnaBI site, into which the
neor cassette had been inserted
(29), or by the absence of the 1,958-bp
BglII/BamHI fragment hybridizing with the X
probe. (B) Results of the nested PCR using genomic DNA from
U87-MGneor clones 1 through 16 as a template.
Cosmids pMVX-lacZ and pMVX-lacZneo, which contain
the unmodified target region and the target region with an inserted
neor cassette, respectively, and DNA from
original U87MG cells were used as controls. Note that the 2,093-bp
product characteristic of the modified target region (and of unspecific
integration of MVX-lacZneo) was not generated under the PCR
conditions used. (C) Results of the Southern blot analysis with genomic
DNA from U87-MGneor clones 1 through 16. Besides
integrated MVX-lacZneo sequences (MVX), the unmodified
X-chromosomal target region (X) was present in all clones.
BglII/BamHI-digested cosmid
pMVX-lacZneo was used as a positive control (PC; one and
three copies/cell); DNA from original U87-MG cells was used as a
negative control (NC).
|
|
MVX-lacZneo integrates completely, with no or little
loss of sequences at the vector ends.
In the previous experiments
no evidence for the involvement of homologous or homology-mediated
mechanisms involving specific sequences of the X-chromosomal backbone
in MVX-lacZneo integration was found. We therefore suspected
that the enhanced number of clones obtained after infection with
MVX-lacZneo compared to Ad
E1neo might be due
not to different integration behavior but results from other
mechanisms. We wanted to test whether MVX-lacZneo, like AE1
adenovirus vectors (27, 31, 61, 62), integrates at full
length. To this end, Southern hybridization experiments were performed
with probes for the Ad5 packaging signal (5' end,
probe) (Fig.
5B) and the SV40 poly(A) signal (3' end,
SV40pA probe) (Fig. 5C), using
BamHI/BglII-digested DNA from
U87-MGneor clones 1 through 16. In 8 of 16 clones (50%) both termini were detected (clones 2, 3, 4, 9, 10, 12, 15, and 16). Five of the remaining clones were positive only with the
probe (clones 1, 6, 8, 11, and 13), two were positive only with the
SV40pA probe (clones 5 and 7), and only in clone 14 was no signal
detected with either probes. These data were confirmed by analysis for
-galactosidase activity of these clones and an additional 15 clones
(total, 31). In 25 clones (80.6%),
-galactosidase activity was
clearly detected, indicating integration of the lacZ
cassette located at the 3' end of MVX lacZneo. Table
2 summarizes the results for
U87-MGneor clones 1 through 16. As expected, all
clones that had been positive with the SV40pA probe in the Southern
analysis expressed
-galactosidase. Interestingly,
-galactosidase
activity was also detected in three of six clones that were negative
with the SV40pA probe (clones 6, 13, and 14), indicating that in these
clones, integration involved loss of 3'-terminal sequences after the
lacZ ORF. Thus, in 13 of 16 clones, MVX-lacZneo
obviously had integrated completely with no or little loss of sequences
at both ends. The sizes of the terminal fragments detected by Southern
blot varied, indicating insertion at different chromosomal sites. In
two clones (clones 2 and 4) (Fig. 5B and C, lanes 6 and 8, respectively), a fragment of similar apparent size hybridized with both
probes. This might indicate joining of vector ends prior to
integration, especially in clone 4, where the size of the fragment
(slightly above 2 kb) would be consistent with a direct head-to-tail
junction (1,515 bp plus 596 bp from the 5'- and 3'-terminal fragments,
respectively). There was a discrepancy between the signal intensities
and the number of signals after hybridization with the
probe and
the SV40pA probe. With the SV40pA probe, only one signal was detected in positive clones. Furthermore, signal intensities were very similar
and may correspond to ~1 copy per genome as determined by comparison
with the positive controls. With the
probe, signal intensities
strongly varied. Intense signals correlated with a high copy number of
integrated neor cassettes (Fig. 4B), especially
in clones 11 and 12 Fig. 4B and 5B, lanes 15 and 16, respectively).
Furthermore, more than one band hybridizing with the
probe was
present in five clones (clones 2, 6, 11, 12, and 16). Thus, although
both ends of MVX-lacZneo were detected in most clones,
sequences from the 3' end were underrepresented in many clones compared
to sequences from the 5' end and the neor
cassette.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 5.
Southern blot analysis for the presence of the 3' and 5'
ends of MVX-lacZneo in U87-MGneor
clones 1 through 16. (A) Genomic DNA was digested with BglII
and BamHI which cut at the indicated positions at the 3' and
5' ends of MVX-lacZneo, respectively (A). For hybridization,
probes specific for the packaging signal at the 3' end ( probe) and
the SV40 polyadenylation signal at the 5' end of MVX-lacZneo
(SV40pA probe) were used. (B and C) Results with the probe and the
SV40pA probe, respectively. Fragments with similar sizes recognized by
both probes which may indicate joined vector ends are marked by
asterisks. Note that BglII/BamHI-digested
pMVX-lacZneo, which was used as a positive control (PC; one
and three copies/cell, respectively), generates fragments with sizes of
6,901 and 596 bp that hybridize with the probe and the SV40pA
probe, respectively (arrows). DNA from original U87-MG cells was used
as a negative control (NC).
|
|
Integrated MVX-lacZneo sequences are located at a
single chromosomal site.
FISH analyses with spread metaphase
chromosomes using the complete MVX-lacZneo sequence as a
probe were performed with three U87-MGneor
clones (clones 2, 11, and 15) that exhibited overrepresentation of
sequences from the 5' terminus and the neor
cassette and/or more than one specific fragment detected with the
probe. Several metaphases analyzed for each clone gave identical signal
patterns, confirming clonality of the cell populations. Representative
results are shown in Fig. 6. As expected,
in all clones a signal was detected at the distal part of the q arm of the X chromosome, the region from which the stuffer sequences in
MVX-lacZneo were derived. Only one additional signal
representing the integration site of MVX-lacZneo sequences
was detected for each clone. The integration site was located on
different chromosomes as judged by chromosome morphology.
Interestingly, the signal resulting from integrated
MVX-lacZneo sequences had an intensity similar to that of
the signal at Xq in clones 2 and 15, whereas in clone 11 it was clearly
severalfold more intense. Thus, signal intensities corresponded to the
estimated number of integrated neor sequences
and multiple copies of MVX-lacZneo sequences in clone 11 colocalized at a single integration site.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 6.
FISH analysis for integrated MVX-lacZneo
sequences. pMVX-lacZneo, which contains the genome of
MVX-lacZneo, was labeled with SpectrumOrange-dUTP and used
as a probe to detect integrated MVX-lacZneo sequences on
spread metaphase chromosomes of U87MG-neor
clones 2, 11, and 15. For each clone two signals were detected. X, X
chromosome with the probe hybridizing to the distal part of the q arm,
the region from where the X-chromosomal backbone in the vector was
derived; MVX, integration site of MVX-lacZneo sequences.
|
|
 |
DISCUSSION |
MVX-lacZneo and U87-MG cells were particularly suited
to analysis of the influence of homologies shared by minimal adenovirus vectors and the target cell genome on vector integration pattern for
the following reasons: (i) the neor cassette in
the vector was inserted centrally into the 27.4-kb stuffer derived from
human noncoding genomic DNA from chromosome X, resulting in ~14 kb of
sequences on both sides of the marker which are homologous to the
target site on human chromosome X; (ii) the neor
cassette in the vector was furthermore flanked by an L1 and an Alu repeat element, which have more than 105
related sequences each in the human genome; and (iii) U87-MG cells are
monosomic for the X chromosome (54), which facilitates the
detection of targeting events. However, no homology-mediated integration events of MVX-lacZneo sequences could be
detected. Instead, our data indicate that the minimal adenovirus vector had integrated completely, with no or little loss of sequences at the
vector ends. The sizes of fragments hybridizing with probes for the
vector termini were different, indicating insertion at different
chromosomal sites. The pattern of hybridizing fragments was consistent
with a head-to-tail junction for 2 of 16 clones.
Thus, the integration pattern of MVX-lacZneo resembles that
of E1 deletion adenovirus vectors carrying a selectable gene, which in
a number of previous studies was shown to involve in most cases the
insertion of a single viral genome into the host cell genome with no or
little loss of sequences at the vector ends, apparently at random sites
(27, 31, 61, 62). Occasionally, multiple copies of vector
DNA arranged in tandem arrays have been found (27, 62),
which is also a common phenomenon with wild-type Ad12 integration into
nonpermissive hamster cells (15). Multimeric insertion of
viral DNA with linkage of the left- and right-hand ends of the viral
genomes, either by direct linkage of the viral ends or with short
stretches of intervening cellular DNA, has been observed upon
integration of Ad2 and Ad5 (63, 64, 65). The organization
of the integrated MVX-lacZneo sequences clearly indicates
that the homologies of the X-chromosomal backbone of the vector to the
host cell genome were not the cause of the enhanced number of
G418-resistant clones generated after infection with this
vector, compared to the E1 deletion vector Ad
E1neo, which shared no homologies with the target cell genome. From the structure of
the integrated MVX-lacZneo sequences and considering the low MOI (0.01 IP/cell) used for the infections, we speculate that the
typical initial event was the unspecific integration of a single
complete linear monomer. Given the low MOI, it is unlikely that the
possible presence of a head-to-tail junction of the vector termini in 2 of 16 clones was indicative of a concatemeric insertion of more than
one vector genome. Instead, in these clones, circularization of the
vector genome prior to integration might have occurred, since wild-type
adenovirus does circularize, at low efficiency, during productive
infection (55), and similar events might also have
occurred to some extent after transduction with the minimal vector.
Lack of viral coding genes in the minimal vector might have played a
role in this process, as the E4 region was shown to antagonize joining
of viral ends (68).
The reason for the enhanced apparent integration frequency of the
minimal vector remains speculative. Different integration frequencies
could, in theory, be explained by loss of terminal vectors sequences
during the integration event, as the neor
cassette was located at the 5' end in the E1 deletion vector, whereas
it was located centrally in the minimal vector. As mentioned above,
however, loss of larger parts of the vector termini is obviously a rare
event during integration of E1 deletion or minimal adenovirus vectors.
Furthermore, in 80% of the neor clones
generated after infection with the minimal vector, the lacZ
expression cassette, which is located at the 3' terminus of the minimal
vector and which was not selected for, was present (Table 2). Thus,
whereas loss of terminal sequences could explain minor differences in
the integration frequency, it cannot account for a 10-fold-reduced
integration frequency of the E1 deletion vector compared to the minimal
vector. Interestingly, our results are very similar to those obtained
by Harui et al. (27) with a minimal adenovirus vector
containing a selectable
-geo gene, which in various
mammalian cells exhibited an up-to-50-fold-higher integration frequency
than a
E1 adenovirus vector with the same expression cassette
inserted into the E1 region, reaching more than 1% integration
frequency in CHO cells. Importantly, the
-geo expression
cassette was located at the vector ends in both vectors. The minimal
vector furthermore differed from the one in the present study in that
it contained a stuffer which was composed entirely of repeated
bacterial sequences from plasmid pBR and not of human chromosomal DNA.
The similarity of their results and ours therefore adds further proof
for our conclusions that (i) loss of terminal sequences during the
integration process cannot be the reason for the reduced number of
neor clones generated after infection with the
E1 deletion vector and (ii) homologies between the vector and the host
cell genome (i.e., chromosomal stuffer elements) per se do not
influence the integration pattern of minimal adenovirus vectors.
The enhanced efficiency of minimal adenovirus vectors to stably
transduce selectable genes might have been mediated by the absence of
viral genes. These are expressed at low levels from first-generation
adenovirus vectors (11, 71, 72, 73) and may inhibit normal
cellular machinery upon vector integration. Transient adenovirus gene
expression might also have occurred in some cells after infection with
the minimal vector, due to the contamination with the E1 deletion
helper virus. However, nonintegrated helper virus genomes will be
diluted out after some cell divisions. Furthermore, integration of both
helper virus and minimal virus into the genome of a given cell can
practically be excluded, considering the low MOIs used and the
integration rates of the E1 deletion and minimal vectors determined in
our study. The reduced number of stably transduced clones after
infection of first-generation adenovirus vectors might therefore
reflect not a reduced integration frequency but rather the need for a balanced expression of the adenovirus genes and the selectable gene.
However, other factors may also contribute. Adenovirus E4orf3 and
E4orf6 can act to inhibit recombination and double strand break (DSB)
repair under replicative conditions (5, 46). These viral
genes are present in the E1 deletion vector but not in the minimal
vector. Thus, although U87-MG cells do not allow replication of the E1
deletion vector, it cannot be excluded that specific viral functions
contribute to reduce the integration frequency of the E1 deletion vector.
These conclusions imply that the incorporation into minimal adenovirus
vectors of stuffer elements derived from noncoding human genomic DNA
most probably does not lead to an enhanced risk of insertional
mutagenesis by homologous or homology-related recombination events.
This is highly relevant for the design of minimal adenovirus vectors as
tools for in vivo gene transfer, as minimal adenovirus vectors with
stuffer elements composed of human chromosomal DNA were shown to allow
long-term gene expression in vivo in a number of studies (8, 42,
44, 51, 56, 57), whereas the incorporation of a stuffer element
derived from phage lambda led to rapid loss of transduced cells by a
stuffer-directed immune response (51). This phenomenon was
suspected to be related to the presence of immunostimulatory CpG
elements (reviewed in reference 34) in bacterial and phage
DNA and the suppression of these elements in mammalian genomic DNA.
Although much work has been dedicated to the issue, no specific sites
or mechanisms for adenovirus integration have been found (16, 19,
23). However, a few base pairs of homology between the vector
and the host cell chromosome were occasionally present at the
integration site (16, 19, 23). This is very similar to the
products generated by nonhomologous end joining (NHEJ), which in
mammalian cells is the most prominent repair mechanism for DNA DSBs and
was recently found to be also involved in retrovirus DNA integration
(12). NHEJ results in ligation of nonhomologous DNA ends
without nucleotide loss or generates products in which only a few
nucleotides are deleted where ligation has taken place at short regions
of microhomology between the two recombining ends (for a recent review
see reference 18). It is therefore tempting to speculate
that adenovirus vectors are recognized as substrates for NHEJ, leading
to integration of the complete vector at sites of DSBs, which arise by
errors in DNA metabolism (36). Interestingly, the
integration frequency of adenovirus vectors was shown to dramatically
increase upon treatment of cells with ionizing radiation, which induces
DSBs (75). In this context it should also be mentioned
that in U87-MGneor clone 11, the
MVX-lacZneo sequences were located in a deviative chromosome
which had resulted from an interchromosomal translocation, with the
insertion site being the junction site (data not shown).
It is widely assumed that adenovirus vectors integrate at low
frequency, which is regarded as an advantage for in vivo gene transfer
because it minimizes the risk of insertional mutagenesis of
cancer-related genes. Our study and previous findings (27, 31,
62), however, indicate that the ability of adenovirus vectors to
integrate into host cell chromosomes is actually high compared to that
of naked plasmid DNA, although the end is protected by the terminal
protein. The apparent integration frequency of Ad
E1neo in
U87-MG cells (0.02%) was in good agreement with earlier studies, which
involved E1 deletion adenovirus vectors carrying a
neor gene and various mammalian cell lines and
were performed under very similar experimental conditions (27,
62). As discussed above, the severalfold-enhanced apparent
integration frequency of the minimal adenovirus vector possibly gives a
better estimate of the integration frequency of adenovirus vectors in
general, which might therefore be higher than suspected so far.
Furthermore, even this integration frequency may be an underestimate,
since under the conditions used not every infectious particle present actually infects a target cell (47) and not every
integration event would be expected to lead to the generation of stably
transduced clone, as local effects at the integration site (e.g.,
silencers or higher-order silencing chromatin structures) may repress
sufficient marker gene expression in some cases. In contrast to
wild-type Ad12, the integration of which in hamster cells has been
extensively studied as a model system for in vivo oncogenesis
(17), the integration of recombinant adenovirus vectors in
vivo is poorly investigated. There are reports that suggest that
adenovirus vectors do integrate after in vivo gene transfer into
animals (7, 49), although no transmission into the germ
line was observed in mice after administration of a
E1/
E4
adenovirus (74). Considering the high viral doses that are
usually envisaged for gene therapy applications, the risk of
insertional mutagenesis after in vivo gene transfer by adenoviral
vectors is an essentially unsolved issue that will need direct examination.
The high efficiency of adenovirus vector integration at random sites is
probably sufficient to explain the fact that in none of 200 clones
tested could a targeted insertion of MVX-lacZneo sequences
into the X-chromosomal target site via homologous recombination be
detected in the present study. This finding is consistent with the
notion that homologous targeting with viral or plasmid vectors is
generally a rare event in mammalian cells, with an average ratio of
random to targeted insertion of around 1,000:1 (for a recent review,
see reference 36). Thus, the potential of minimal adenovirus vectors for gene targeting strategies seems to be limited, although they can accommodate long stretches of homologous sequences. Interestingly, the limited targeting potential of most viral and nonviral vector systems including the minimal adenovirus vector in the
present study is in striking contrast to the observation that
E1+ and
E1 adenovirus vectors carrying an intact
neor gene are capable of correcting a mutant
neor gene inserted into a host cell's
chromosome with an extraordinarily high ratio (up to 40%) of gene
targeting versus random integration of the complete vector (22,
41, 66). The high targeting rates obtained with these vectors
may be explained by the aforementioned assumption that the integration
of adenovirus coding regions is not tolerated by the host cell in most
cases. If this was true, first generation adenovirus vectors, unlike
minimal adenovirus vectors, would resemble replacement-type vectors for
positive and negative selection that promote homologous targeting
because it leads to loss of the adenovirus coding sequences. This
assumption would also be in agreement with the finding that the
absolute targeting frequencies of the E1+ and
E1 vectors
were not enhanced compared to those of other vector systems (22,
41, 66). Possibly, the targeting rates of minimal adenovirus
vectors could be improved to some minor extent by incorporation of
flanking homologous sequences which were isolated from the cells to be
infected (i.e., which are isogenic), as targeting rates can be reduced
up to fivefold if sequence polymorphisms are present (14).
This approach, however, does not seem very promising, as it would
require the laborious isolation and insertion into the vector of
isogenic sequences for each individual cell line to be infected.
Watson and coworkers have shown that linear plasmid-derived replacement
vectors containing a neor cassette flanked by
two complete L1 repeats or by one complete L1 repeat on one side and an
Alu repeat on the other efficiently integrate via
repeat-mediated homology-like recombination with chromosomal
counterparts of these repeat elements in up to 20% of the clones
(67). The difference between their results and ours might
be related to the different sizes of the L1 elements: the L1 repeat
before the neor cassette in
MVX-lacZneo was severely 5' truncated (total of 225 bp,
matching bp 5893 to 6122 of the 6,146-bp consensus) (Table 1). As most
genomic L1 elements are also 5' truncated, retaining only the 100 to
1,000 3' terminal bp of the 6-kb full-length element (48),
this did not reduce the high number of related sequences in the genome.
However, the L1 element (and the 296-bp Alu element at the
other side of the neor cassette) might have been
too short to promote homology-like recombination at a significant rate.
Interestingly, in the study by Watson and coworkers (67),
a vector carrying the neor gene flanked by two
repeats of the Alu family (< 300 bp in length) did not
exhibit repeat-mediated integration. Their and our data are therefore
in agreement with the assumption that ~300 bp of imperfect homology
does not suffice to mediate homologous recombination of targeting
vectors in mammalian cells (58, 60).
During clonal growth under selection, rearrangements of integrated
MVX-lacZneo sequences seem to have occurred in some clones that led to amplification of the neor gene, as
visualized by the band intensities in Fig. 4B. Growth under G418
selection could have been the driving force for these rearrangements
despite the neor gene being driven by the strong
CMV promoter, because its activity could have been reduced to various
extents by silencing cis-active elements at the integration
sites or by trans-acting silencing mechanisms
(10). Interestingly, sequences from the 5' end of the
vector were also overrepresented in most clones containing multiple
copies of the neo gene, whereas sequences from the 3' end of
the vector were underrepresented in these clones, being either absent
or present only at ~1 copy/cell. This phenomenon was most pronounced
in U87-MGneor clone 11, where multiple copies of
the neor gene and the packaging signal (5' end)
were present but no sequences from the 3' end of the vector were
detected. These multiple sequences all colocalized to a single
chromosomal site (Fig. 6). Interestingly, the density of chromosomal
repeat elements in the backbone of MVX-lacZneo was
significantly higher downstream of the neor
cassette, with 11 of total 15 elements and namely all four
Alu elements being located in this region (Table 1).
Alu elements occur at an average of one per 3 to 6 kb in the
human genome but are completely absent in MVX-lacZneo
upstream of the neor cassette. Thus,
recombination between Alu elements located 5' of the
MVX-lacZneo integration site and the Alu elements
in the 3' terminal part of the vector which would result in
amplification of the neor gene by unequal
crossover events would, at the same time, amplify the complete 5'
sequences of pMVX-lacZneo, whereas sequences in the 3' part
of the vector would not be amplified. It therefore seems likely that
growth under selection led to the amplification of the
neor cassette by repeat-mediated
intrachromosomal rearragements. In fact, chromosomal rearrangements due
to recombination between Alu elements represent a major
source of genome plasticity and have been related to a variety of
deseases in humans (reviewed in reference 13). Similarly,
rearrangements of integrated minimal adenovirus vector sequences were
also reported by Harui and colleagues (27) and were
attributed to the repetitive nature of the backbone in their vector.
These conclusions have important implications for the potential use of
minimal adenovirus vectors as tools for the generation of stable cell
lines and transgenic animals, which is a promising strategy in cases
where transduction of the cells by conventional transfection techniques
is too inefficient. Minimal adenovirus vectors would be particularly
interesting for these purposes for a number of reasons: (i) as
adenovirus vectors, they infect a large variety of cell types at high
efficiency; (ii) they obviously integrate at high efficiency, primarily
as one complete monomer per cell; (iii) the high capacity of these
vectors could enable stable transfer of genes together with complex
regulatory elements to achieve regulated or tissue-specific expression;
and (iv) adverse effects mediated by residual adenovirus gene
expression are excluded. From our data we conclude that in the design
of vectors for these purposes it will be important to exclude
chromosomal repeat elements or internally redundant sequences from the
vector in order to maintain vector structure upon integration.
 |
ACKNOWLEDGMENTS |
We acknowledge the excellent technical assistance of Heidrun
Peter and Uta Fischer with the cell culture work and of Antje Gerlach
with the FISH experiments. We thank David Bauer for help with the
computer analyses and Frank Schnieders for helpful discussions. Finally, we thank Gary S. Jennings, Peter Löser, and Christian Hofmann for critical reading of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: DeveloGen AG,
Robert-Rössle-Str. 10, D-13125 Berlin-Buch, Germany. Phone:
49-30-9489-2290. Fax: 49-30-9489-2913. E-mail:
mhillgenberg{at}hepavec.com.
 |
REFERENCES |
| 1.
|
Alemany, R.,
Y. Dai,
Y. C. Lou,
E. Sethui,
E. Prokopenko,
S. F. Josephs, and W.-W. Zhang.
1997.
Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations.
J. Virol. Methods
68:147-159[CrossRef][Medline].
|
| 2.
|
Altschul, S. F.,
T. L. Madden,
A. A. Schaeffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402[Abstract/Free Full Text].
|
| 3.
|
Benihoud, K.,
P. Yeh, and M. Perricaudet.
1999.
Adenovirus vectors for gene delivery.
Curr. Opin. Biotechnol.
10:440-447[CrossRef][Medline].
|
| 4.
|
Bett, A. J.,
W. Haddara,
L. Prevec, and F. L. Graham.
1994.
An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.
Proc. Natl. Acad. Sci. USA
91:8802-8806[Abstract/Free Full Text].
|
| 5.
|
Boyer, J.,
K. Rohleder, and G. Ketner.
1999.
Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase.
Virology
263:307-312[CrossRef][Medline].
|
| 6.
|
Brand, K.,
R. Klocke,
A. Possling,
D. Paul, and M. Strauss.
1999.
Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection.
Gene Ther.
6:1054-1063[CrossRef][Medline].
|
| 7.
|
Brown, G. R.,
D. L. Thiele,
M. Silva, and B. Beutler.
1997.
Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium.
Gastroenterology
112:1586-1594[CrossRef][Medline].
|
| 8.
|
Chen, H.-H.,
L. M. Mack,
R. Kelly,
M. Ontell,
S. Kochanek, and P. R. Clemens.
1997.
Persistence in muscle of an adenoviral vector that lacks all viral genes.
Proc. Natl. Acad. Sci. USA
94:1645-1650[Abstract/Free Full Text].
|
| 9.
|
Chen, H.-H.,
L. M. Mack,
S.-Y. Choi,
M. Ontell,
S. Kochanek, and P. R. Clemens.
1999.
DNA from both high-capacity and first-generation adenoviral vectors remain intact in skeletal muscle.
Hum. Gene Ther.
10:365-373[CrossRef][Medline].
|
| 10.
|
Chen, W. Y.,
E. C. Bailey,
S. L. McCune,
J.-Y. Dong, and T. M. Townes.
1997.
Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.
Proc. Natl. Acad. Sci. USA
94:5798-5803[Abstract/Free Full Text].
|
| 11.
|
Dai, Y.,
E. M. Schwarz,
D. Gu,
W. W. Zhang,
N. Sarvetnick, and I. M. Verma.
1995.
Cellular and humoral responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long term expression.
Proc. Natl. Acad. Sci. USA
92:1401-1405[Abstract/Free Full Text].
|
| 12.
|
Daniel, R.,
R. A. Katz, and A. M. Skalka.
1999.
A role for DNA-PK in retroviral DNA integration.
Science
284:644-647[Abstract/Free Full Text].
|
| 13.
|
Deininger, P. L., and M. A. Batzer.
1999.
Alu repeats and human desease.
Mol. Gen. Metab.
67:183-193[CrossRef][Medline].
|
| 14.
|
Deng, C., and M. R. Capecchi.
1992.
Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus.
Mol. Cell. Biol.
12:3365-3371[Abstract/Free Full Text].
|
| 15.
|
Doerfler, W.
1982.
Uptake, fixation, and expression of foreign DNA in mammalian cells: the organization of integrated adenovirus DNA sequences.
Curr. Top. Microbiol. Immunol.
101:127-194[Medline].
|
| 16.
|
Doerfler, W.
1995.
The integration of foreign DNA into mammalian genomes and its consequences: a concept for oncogenesis.
Adv. Cancer Res.
66:313-344[Medline].
|
| 17.
|
Doerfler, W.
1996.
A new concept in (adenoviral) oncogenesis: integration of foreign DNA and its consequences.
Biochim. Biophys. Acta
1288:F79-F99[Medline].
|
| 18.
|
Featherstone, C., and S. P. Jackson.
1999.
Ku, a DNA repair protein with multiple cellular functions?
Mutat. Res.
434:3-15[Medline].
|
| 19.
|
Fechteler, K.,
J. Tatzelt,
S. Huppertz,
P. Wilgenbus, and W. Doerfler.
1995.
The mechanism of adenoviral DNA integration: studies in a cell-free system.
Curr. Top. Microbiol. Immunol.
199:109-137.
|
| 20.
|
Fisher, K. J.,
H. Choi,
J. Burda,
S.-J. Chen, and J. M. Wilson.
1996.
Recombinant adenovirus deleted for all viral genes for gene therapy of cystic fibrosis.
Virology
217:11-22[CrossRef][Medline].
|
| 21.
|
Fisher, P. B.,
L. E. Babiss,
I. B. Weinstein, and H. S. Ginsberg.
1982.
Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF).
Proc. Natl. Acad. Sci. USA
79:3527-3531[Abstract/Free Full Text].
|
| 22.
|
Fujita, A.,
K. Sakagami,
Y. Kanagae,
I. Saito, and I. Kobayashi.
1995.
Gene targeting with a replication-defective adenovirus vector.
J. Virol.
69:6180-6190[Abstract].
|
| 23.
|
Gahlmann, R.,
R. Leisten,
L. Vardimon, and W. Doerfler.
1982.
Patch homologies and the integration of adenovirus DNA in mammalian cells.
EMBO J.
1:1101-1104[Medline].
|
| 24.
|
Graham, F. L.,
J. Smiley,
W. C. Russell, and R. Nairn.
1977.
Characteristics of a human cell line transformed by DNA from a human adenovirus type 5.
J. Gen. Virol.
36:59-74[Abstract/Free Full Text].
|
| 25.
|
Haecker, S. E.,
H. H. Stedman,
R. J. Balice-Gordon,
D. B. J. Smith,
J. P. Greelish,
M. A. Mitchell,
A. Wells,
H. L. Sweeney, and J. M. Wilson.
1996.
In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes.
Hum. Gene Ther.
7:1907-1914[Medline].
|
| 26.
|
Hardy, S.,
M. Kitamura,
T. Harris-Stansil,
Y. Dai, and L. M. Phillips.
1997.
Construction of adenovirus vectors through Cre/lox-recombination.
J. Virol.
71:1842-1849[Abstract].
|
| 27.
|
Harui, A.,
S. Suzuki,
S. Kochanek, and K. Mitani.
1999.
Frequency and stability of chromosomal integration of adenovirus vectors.
J. Virol.
73:6141-6146[Abstract/Free Full Text].
|
| 28.
|
Hehir, K. M.,
D. Armetano,
L. M. Cardoza,
T. L. Choquette,
P. B. Berthelette,
G. A. White,
L. A. Couture,
M. B. Everton,
J. Keegan,
J. M. Martin,
D. A. Pratt,
M. P. Smith,
A. E. Smith, and S. C. Wadsworth.
1996.
Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
J. Virol.
70:8459-8467[Abstract].
|
| 29.
|
Hillgenberg, M.,
F. Schnieders,
P. Löser, and M. Strauss.
2001.
System for efficient helper-dependent minimal adenovirus construction and rescue.
Hum. Gene Ther.
12:643-657[CrossRef][Medline].
|
| 30.
|
Kanagae, Y.,
M. Makimura, and I. Saito.
1994.
A simple and efficient method for purification of infectious recombinant adenovirus.
Jpn. J. Med. Sci. Biol.
47:157-166[Medline].
|
| 31.
|
Karlsson, S.,
K. Van Doren,
S. G. Schweiger,
A. W. Nienhuis, and Y. Gluzman.
1986.
Stable gene transfer and tissue-specific expression of a human globin gene using adenoviral vectors.
EMBO J.
5:2377-2385[Medline].
|
| 32.
|
Karlsson, S.,
R. K. Humphries,
Y. Gluzman, and A. W. Nienhuis.
1985.
Transfer of genes into hematopoietic cells using recombinant DNA viruses.
Proc. Natl. Acad. Sci. USA
82:158-162[Abstract/Free Full Text].
|
| 33.
|
Kochanek, S.,
P. R. Clemens,
K. Mitani,
H.-H. Chen,
S. Chan, and C. T. Caskey.
1996.
A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and -galactosidase.
Proc. Natl. Acad. Sci. USA
93:5731-5736[Abstract/Free Full Text].
|
| 34.
|
Krieg, A. M.,
A.-K. Yi, and G. Hartmann.
1999.
Mechanisms and therapeutic applications of immune stimulatory CpG DNA.
Pharmacol. Ther.
84:113-120[CrossRef][Medline].
|
| 35.
|
Kumar-Singh, R., and J. S. Chamberlain.
1996.
Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.
Hum. Mol. Genet.
5:913-921[Abstract/Free Full Text].
|
| 36.
|
Lanzov, V. A.
1999.
Gene targeting for gene therapy: prospects.
Mol. Genet. Metab.
68:276-282[CrossRef][Medline].
|
| 37.
|
Maizel, J. V.,
D. O. White, and M. D. Scharff.
1968.
The polypeptides of adenovirus. I. Evidence for multiple components in the virion and a comparison of types 2, 7A, and 12.
Virology
36:115-125[CrossRef][Medline].
|
| 38.
|
McGrory, W. J.,
D. S. Bautista, and F. L. Graham.
1988.
A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5.
Virology
163:614-617[CrossRef][Medline].
|
| 39.
|
Mighell, A. J.,
A. F. Markham, and P. A. Robinson.
1997.
Alu sequences.
FEBS Lett.
417:1-5[CrossRef][Medline].
|
| 40.
|
Mitani, K.,
F. L. Graham,
C. T. Caskey, and S. Kochanek.
1995.
Rescue, propagation and partial purification of a helper-dependent adenovirus vector.
Proc. Natl. Acad. Sci. USA
92:3854-3858[Abstract/Free Full Text].
|
| 41.
|
Mitani, K.,
M. Wakamiya,
P. Hasty,
F. L. Graham,
A. Bradley, and C. T. Caskey.
1995.
Gene targeting in mouse embryonic stem cells with an adenoviral vector.
Somat. Cell Mol. Genet.
21:221-231[CrossRef][Medline].
|
| 42.
|
Morral, N.,
R. J. Parks,
H. Zhou,
C. Langston,
G. Schiedner,
J. Quitones,
F. L. Graham,
S. Kochanek, and A. L. Beaudet.
1998.
High doses of a helper-dependent adenoviral vector yield supraphysiological levels of 1-antitrypsin with negligible toxicity.
Hum. Gene Ther.
9:2709-2716[Medline].
|
| 43.
|
Morral, N.,
W. O'Neal,
K. Rice,
M. Leland,
J. Kaplan,
P. A. Piedra,
H. Zhou,
R. J. Parks,
R. Velji,
E. Aguilar-Cordova,
S. Wadsworth,
F. L. Graham,
S. Kochanek,
K. D. Carey, and A. L. Beaudet.
1999.
Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.
Proc. Natl. Acad. Sci. USA
96:12816-12821[Abstract/Free Full Text].
|
| 44.
|
Morsy, M. A.,
M. C. Gu,
S. Motzel,
J. Zhao,
J. Lin,
Q. Su,
H. Allen,
L. Franklin,
R. J. Parks,
F. L. Graham,
S. Kochanek,
A. J. Bett, and T. C. Caskey.
1998.
An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.
Proc. Natl. Acad. Sci. USA
95:7866-7871[Abstract/Free Full Text].
|
| 45.
|
Nakabayashi, H.,
K. Taketa,
K. Miyano,
T. Yamane, and J. Saito.
1982.
Growth of human hepatoma cell lines with differentiated functions in chemically defined medium.
Cancer Res.
42:3858-3863[Abstract/Free Full Text].
|
| 46.
|
Nicolas, A. L.,
P. L. Munz,
E. Falck-Pedersen, and C. S. H. Young.
2000.
Creation and repair of specific DNA double-strand breaks in vivo following infection with adenovirus vectors expressing Saccharomyces cerevisiae HO endonuclease.
Virology
266:211-224[CrossRef][Medline].
|
| 47.
|
Nyberg-Hoffman, C.,
P. Shabram,
W. Li,
D. Giroux, and E. Aguilar-Cordova.
1997.
Sensitivity and reproducibility of adenoviral infectious titer determination.
Nat. Med.
3:808-811[CrossRef][Medline].
|
| 48.
|
Okada, N.,
M. Hamada,
I. Okiwara, and K. Ohshima.
1997.
SINEs and LINEs share common 3' sequences: a review.
Gene
205:229-243[CrossRef][Medline].
|
| 49.
|
Overturf, K.,
M. Al-Dhalimy,
C. N. Ou,
M. Finnegold,
R. Tanguay,
A. Lieber,
M. Kay, and M. Grompe.
1997.
Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type 1.
Hum. Gene Ther.
8:513-521[Medline].
|
| 50.
|
Parks, R. J., and F. L. Graham.
1997.
A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging.
J. Virol.
71:3293-3298[Abstract].
|
| 51.
|
Parks, R. J.,
J. L. Bramson,
Y. Wan,
C. L. Addison, and F. L. Graham.
1999.
Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.
J. Virol.
73:8027-8034[Abstract/Free Full Text].
|
| 52.
|
Parks, R. J.,
L. Chen,
M. Anton,
U. Sankar,
M. A. Rudnicki, and F. L. Graham.
1996.
A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.
Proc. Natl. Acad. Sci. USA
93:13565-13570[Abstract/Free Full Text].
|
| 53.
|
Pinkel, D.,
J. Landegent,
C. Collins,
J. Fuscoe,
R. Segraves,
J. Lucas, and J. Gray.
1988.
Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4.
Proc. Natl. Acad. Sci. USA
85:9138-9142[Abstract/Free Full Text].
|
| 54.
|
Ponten, J., and E. H. Macintyre.
1968.
Long term culture of normal and neoplastic human glia.
Acta Pathol. Microbiol. Scand.
74:465-486[Medline].
|
| 55.
|
Ruben, M.,
S. Bacchetti, and F. Graham.
1983.
Covalently closed circles of adenovirus 5 DNA.
Nature
301:172-174[CrossRef][Medline].
|
| 56.
|
Sandig, V.,
R. Youil,
A. J. Bett,
L. L. Franlin,
M. Oshima,
D. Maione,
F. Wang,
K. L. Metzker,
R. Savino, and T. C. Caskey.
2000.
Optimization of the helper-dependent adenovirus system for production and potency in vivo.
Proc. Natl. Acad. Sci. USA
97:1002-1007[Abstract/Free Full Text].
|
| 57.
|
Schiedner, G.,
N. Morral,
R. J. Parks,
Y. Wu,
S. C. Koopmans,
C. Langston,
F. L. Graham,
A. Beaudet, and S. Kochanek.
1998.
Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxixity.
Nat. Genet.
18:180-183[CrossRef][Medline].
|
| 58.
|
Shen, M. R., and P. L. Deininger.
1992.
An in vivo assay for measuring the recombination potential between DNA sequences in mammalian cells.
Anal. Biochem.
205:83-89[CrossRef][Medline].
|
| 59.
|
Stratford-Perricaudet, L. D.,
I. Makeh,
M. Perricaudet, and P. Briand.
1992.
Widespread long-term gene transfer to mouse skeletal muscles and heart.
J. Clin. Investig.
90:626-630.
|
| 60.
|
Thomas, K. R.,
C. Deng, and M. R. Capecchi.
1992.
High-fidelity gene targeting in embryonic stem cells by using sequence replacement vectors.
Mol. Cell. Biol.
12:2919-2923[Abstract/Free Full Text].
|
| 61.
|
Tsukui, T.,
Y. Kanagae,
I. Saito, and Y. Toyoda.
1996.
Transgenesis by adenovirus-mediated gene transfer into zona-free eggs.
Nat. Biotechnol.
14:982-985[CrossRef][Medline].
|
| 62.
|
Van Doren, K.,
D. Hanahan, and Y. Gluzman.
1984.
Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA.
J. Virol.
50:606-614[Abstract/Free Full Text].
|
| 63.
|
Visser, L.,
A. C. Reemet,
A. D. van Mansfeld, and T. H. Rozijn.
1982.
Nucleotide sequence analysis of the linked left and right hand terminal regions of adenovirus type 5 DNA present in the transformed rat cell line 5RK20.
Nucleic Acids Res.
10:2189-2198[Abstract/Free Full Text].
|
| 64.
|
Visser, L.,
A. T. Wassenaar,
M. W. van Maarschalkerweerd, and T. H. Rozijn.
1981.
Arrangement of integrated viral DNA sequences in cells transformed by adenovirus types 2 and 5.
J. Virol.
39:684-693[Abstract/Free Full Text].
|
| 65.
|
Visser, L.,
M. W. van Maarschalkerweerd,
T. H. Rozijn,
A. T. Wassenaar,
A. C. Reemet, and J. S. Sussenbach.
1979.
Viral DNA sequences in adenovirus transformed cells.
Cold Spring Harbor Symp. Quant. Biol.
44:541-550.
|
| 66.
|
Wang, Q., and M. W. Taylor.
1993.
Correction of a deletion mutant by gene targeting with an adenoviral vector.
Mol. Cell. Biol.
13:918-927[Abstract/Free Full Text].
|
| 67.
|
Watson, J. E. V.,
E. M. Slorach,
J. Maule,
D. Lawson,
D. J. Porteous, and A. J. Brookes.
1995.
Human repeat-mediated integration of selectable markers into somatic cell hybrids.
Genome Res.
5:444-452[Abstract/Free Full Text].
|
| 68.
|
Weiden, M. D., and H. S. Ginsberg.
1994.
Deletion of the E4 region of the genome produces adenovirus DNA concatemers.
Proc. Natl. Acad. Sci. USA
91:153-157[Abstract/Free Full Text].
|
| 69.
|
Weiner, A. M.,
P. L. Deininger, and A. Efstratiadis.
1986.
Nonviral retroposons: genes, pseudogenes, and transposable elements generated by the reverse flow of genetic information.
Annu. Rev. Biochem.
55:631-661[CrossRef][Medline].
|
| 70.
|
Yanez, R. J., and A. C. G. Porter.
1998.
Therapeutic gene targeting.
Gene Ther.
5:149-159[CrossRef][Medline].
|
| 71.
|
Yang, Y.,
H. C. Ertl, and J. M. Wilson.
1994.
MHC class I restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1 deleted recombinant adenoviruses.
Immunity
1:433-442[CrossRef][Medline].
|
| 72.
|
Yang, Y.,
Q. Li,
H. C. Ertl, and J. M. Wilson.
1994.
Cellular immunity to viral antigens limits E1-deleted recombinant adenoviruses for gene therapy.
Proc. Natl. Acad. Sci. USA
91:4407-4411[Abstract/Free Full Text].
|
| 73.
|
Yang, Y.,
Q. Li,
H. C. Ertl, and J. M. Wilson.
1995.
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.
J. Virol.
69:2004-2015[Abstract].
|
| 74.
|
Ye, X.,
G. P. Gao,
C. Pabin,
S. E. Raper, and J. M. Wilson.
1998.
Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse.
Hum. Gene Ther.
9:2135-2142[Medline].
|
| 75.
|
Zeng, M.,
G. J. Cerniglia,
S. L. Eck, and C. W. Stevens.
1997.
High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation.
Hum. Gene Ther.
8:1025-1032[Medline].
|
| 76.
|
Zhang, W.-W.,
S. F. Josephs,
J. Zhou,
X. Fang,
R. Alemany,
C. Belagué,
Y. Dai,
D. Ayares,
E. Prokopenko,
Y.-C. Lou,
E. Sethi,
D. Hubert-Leslie,
M. Kennedy,
L. Ruiz, and S. Rockow-Magnone.
1999.
Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A.
Thromb. Haemostasis
82:562-571[Medline].
|
Journal of Virology, October 2001, p. 9896-9908, Vol. 75, No. 20
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9896-9908.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, H., Shayakhmetov, D. M., Leege, T., Harkey, M., Li, Q., Papayannopoulou, T., Stamatoyannopolous, G., Lieber, A.
(2005). A Capsid-Modified Helper-Dependent Adenovirus Vector Containing the {beta}-Globin Locus Control Region Displays a Nonrandom Integration Pattern and Allows Stable, Erythroid-Specific Gene Expression. J. Virol.
79: 10999-11013
[Abstract]
[Full Text]